title: The role of E-cadherin/beta-catenin complex and cyclin D1 in head and neck squamous cell carcinoma.
abstract: OBJECTIVE
  To determine the relationship between expression pattern of E-cadherin, beta-catenin and cyclin D1, and clinicopathologic parameters in patients with head and neck squamous cell carcinomas (HNSCC).
  
  
  METHODS
  The authors evaluated the immunohistochemical expression pattern of E-cadherin, beta-catenin in relationship with cyclin D1 overexpression, degree of histologic differentiation, clinical stage, and nodal status in 146 head and neck squamous cell carcinomas (HNSCC). The authors also evaluated the expression of E-cadherin/beta-catenin complex, E-cadherin/cyclin D1, and beta-catenin/cyclin D1 double staining with confocal laser scanning microscope.
  
  
  RESULTS
  Aberrant expressions in 78% of E-cadherin, 77% of beta-catenin, and 69% of cyclin D1 in the HNSCC were observed. There was correlation of aberrant expression of E-cadherin and nodal status. Cyclin D1 overexpression was also correlated to clinical stage and nodal status. Significant relation was observed between E-cadherin and beta-catenin expression patterns. Co-expression of E-cadherin and beta-catenin was significantly detected. However, there was no correlation of cyclin D1 overexpression with E-cadherin or beta-catenin expression patterns.
  
  
  CONCLUSIONS
  These results suggest that aberrant expression of E-cadherin, E-cadherin/beta-catenin complex, and cyclin D1 may be involved in clinical stage and/or nodal status, and analysis of the pattern of E-cadherin, cyclin D1, and E-cadherin/beta-catenin complex may be good prognostic marker of HNSCC.
authors.affiliation: Department of Otorhinolaryngology, Chosun University College of Medicine, Gwangju, Korea.
authors.forename: Nam Yong
authors.initials: NY
authors.lastname: Do
authors.forename: Sung Yong
authors.initials: SY
authors.lastname: Park
authors.forename: Sung Chul
authors.initials: SC
authors.lastname: Lim
references.citation: Cancer Res. 1993 Jul 15;53(14):3241-5
references.pmid: 8324734
references.citation: Int J Cancer. 2001 May 20;95(3):194-7
references.pmid: 11307154
references.citation: Cancer Res. 1994 Dec 1;54(23):6282-7
references.pmid: 7954478
references.citation: Nature. 1999 Apr 1;398(6726):422-6
references.pmid: 10201372
references.citation: Genes Dev. 1997 Dec 15;11(24):3286-305
references.pmid: 9407023
references.citation: J Clin Oncol. 2003 May 1;21(9):1708-14
references.pmid: 12721245
references.citation: Expert Rev Anticancer Ther. 2001 Jun;1(1):116-24
references.pmid: 12113118
references.citation: Cancer Res. 1961 Nov;21:1436-8
references.pmid: 13880726
references.citation: Cancer Res. 1996 Sep 15;56(18):4154-8
references.pmid: 8797585
references.citation: Biochem Biophys Res Commun. 1994 Nov 30;205(1):73-8
references.pmid: 7999105
references.citation: J Laryngol Otol. 2003 Apr;117(4):286-93
references.pmid: 12816218
references.citation: Trends Genet. 1993 Sep;9(9):317-21
references.pmid: 8236461
references.citation: Cancer. 1978 Mar;41(3):1170-8
references.pmid: 638961
references.citation: J Clin Pathol. 2001 Jan;54(1):42-7
references.pmid: 11271788
references.citation: Oral Oncol. 2003 Sep;39(6):610-8
references.pmid: 12798405
references.citation: Cell. 1991 May 31;65(5):849-57
references.pmid: 1904011
references.citation: Am J Pathol. 1995 Mar;146(3):605-12
references.pmid: 7534041
references.citation: Am J Pathol. 1997 Feb;150(2):705-11
references.pmid: 9033283
references.citation: Cell. 1993 May 7;73(3):499-511
references.pmid: 8490963
references.citation: Pathol Res Pract. 1993 Nov;189(9):975-8
references.pmid: 8302730
references.citation: Surg Clin North Am. 1996 Apr;76(2):327-41
references.pmid: 8610267
references.citation: Cancer Res Treat. 2003 Feb;35(1):16-24
references.pmid: 26680910
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4262-6
references.pmid: 10759547
references.citation: J Cell Biol. 1992 Apr;117(2):415-25
references.pmid: 1373144
references.citation: Semin Cancer Biol. 1993 Aug;4(4):231-9
references.pmid: 8400145